Facebook (FB) Does Face a Plant, Buy, Sell or Hold
Facebook reported 2nd quarter earnings last night and investors did not like what they heard. The share price fell in aftermarket trading by about $44.25 or 20.3%. This is truly remarkable…
Is it Time to Tune Into AMC Networks?
AMC Networks (AMCX) is a name we have not talked about in the past here at theOptionsEdge.Com. The market capitalization and enterprise value of the company is a bit smaller…
Will You Get Smarter It You Take a Position in IQ?
iQIYI (IQ) is a company we have discussed in the past and have suggested taking a position in the name as well. To refresh your memory, iQIYI China's version of…
The Week Ahead | 07/23/2018
Share buybacks are still going strong. It’s really quite remarkable when you think about it. Payment to shareholders (Dividends and share buybacks) are running at an annual pace of $760…
Facebook Rips, Now What?
The share price of Facebook fell about 20% after the company revealed what everyone already knew. FB both uses and sells customer data as a core element of the company's…
Dr. Copper Gives a Lecture, Or Does He?
The term Doctor Copper is market slang describing the base metal as possessing Ph.D. in economics. It gets the prefix "Doctor" because of its ability to predict turning points in the global…
Don’t Be a Chicken
Consumer staples stocks have been one of the most unloved sectors of the equity market over the past three years or so. The share prices of many of the stocks…
The Equity Markets “Feel” Strong but “Is Something Rotten in the State of Denmark?”
Ever since the 4th of July, the equity markets have found their legs. Prices have moved higher for all the broad popular indexes. But do we have a discernible trend we…
Update | Options Expiration
Standard Monthly Options expire at the end of the week. Since we have 7 open positions to address, we thought we should discuss them so our readers can decide what they…
The Week Ahead 07/16/2018
World Cup France beat Croatia in regular time to win the FIFA World Cup for the second time in its history. Global Spotlight Welcome to the Trade War. The White House…
Can J&J Get High(er)?
On 06-June-2018, Carter Braxton Worth made the bullish technical case for J&J, the ginormous pharmaceutical and healthcare company. He pointed out that J&J has been trading like a consumer staple…
The Fed’s Latest Claim of “Independence” Is As Unconvincing as Ever
Here we go again. A fed official is once again going to the media to repeat the age-old myth that the Fed is totally independent of political influence. This article…